4//SEC Filing
Rosol Michael Stanley 4
Accession 0001437749-22-001026
CIK 0000810509other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 9:28 AM ET
Size
5.2 KB
Accession
0001437749-22-001026
Insider Transaction Report
Form 4
Rosol Michael Stanley
Chief Medical Officer
Transactions
- Award
Common Stock
2022-01-14+7,728→ 14,575 total
Holdings
- 6,816(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Stock issued under the Amended and Restated 2014 Stock Incentive Plan in lieu of cash bonus, as elected by the Reporting Person.
Documents
Issuer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK 0000810509
Entity typeother
Related Parties
1- filerCIK 0001762349
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 9:28 AM ET
- Size
- 5.2 KB